Key facts
- Krishi’s last known valuation is $11.0M (Mar 2026).
- It has raised $2.5M across 3 recorded rounds; the latest was Seed Round ($1.4M) in Mar 2026.
- Notable investors include Purdue Ag-Celerator, Purdue Ventures.
- Krishi has filed 4 Form Ds with the SEC since 2022, most recently Jun 2025 ($515K sold to 8 investors).
- Status: Privately Held (backing).
Investors
2- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Krishi
Funding rounds
3 roundsAbout Krishi
Operator of a biotechnology company intended to provide molecular diagnostics for the agriculture and animal health markets. The company develops disposable diagnostic cartridges in conjunction with an Internet of Things-connected reader that can be used at or near the location of sample collection, enabling agronomists and veterinarians to get laboratory-quality diagnostics without sending samples.
- Sector
- Business Products and Services (B2B)
- HQ
- West Lafayette, IN, United States
- Founded
- 2020
- Employees
- 3
- Website
- krishidiagnostics.com/
- Ownership
- Privately Held (backing)
Krishi doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Krishi shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Krishi in its N-PORT filings yet. We sweep new filings monthly.